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Purpose: To investigate the structural integrity of the superﬁcial capillary plexuses (SCPs) and deep capillary
plexuses (DCPs) using optical coherence tomography (OCT) angiography (OCTA) in patients with diabetic
macular edema (DME) and its association with the response to antievascular endothelial growth factor (VEGF)
treatment.
Design: Retrospective, case-control study.
Participants: We included 51 DME eyes with a poor response to anti-VEGF agents and 32 age-matched
DME eyes with a good response to anti-VEGF treatment, along with 20 fellow eyes without DME from the
cases and controls.
Methods: The medical records, including OCTA and spectral-domain OCT (SD OCT), were reviewed and
compared between the groups. En face OCTA images of the SCP and DCP were obtained for each eye. An anti-
VEGF responder was deﬁned by a reduction of more than 50 mm in central retinal thickness after 3 consecutive
anti-VEGF treatments. A poor responder was deﬁned by a reduction of less than 50 mm or an increase in central
retinal thickness after 3 monthly injections.
Main Outcome Measures: We measured the vascular density and foveal avascular zone (FAZ) area and
counted the number of microaneurysms in each layer. The SD OCT images were compared with OCTA ﬁndings.
Results: Compared with non-DME eyes, DME eyes had a lower vascular density (P < 0.001) and larger FAZ
area (P < 0.001) in the DCP and more microaneurysms (P < 0.001) in both layers. Although there was no sig-
niﬁcant difference in the SCP between anti-VEGF responders and poor responders, poor responders tended to
show greater damage and more microaneurysms in the DCP (P < 0.001) and a larger FAZ area (P < 0.001). The
topographic location of the disrupted synaptic portion of the outer plexiform layer (OPL) in SD OCT exactly
corresponded to the nonﬂow area of the DCP in OCTA.
Conclusions: Compared with DME eyes that responded to anti-VEGF treatment, poor responders show
signiﬁcant damage to the integrity of the DCP, but not the SCP. The degree of OPL disruption in SD OCT cor-
responds well with the extent of DCP loss in DME eyes. The extent of DCP loss and the corresponding OPL
disruption could be useful predictors of responsiveness to anti-VEGF treatment. Ophthalmology 2016;123:2368-
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Supplemental material is available at www.aaojournal.org.Diabetic macular edema (DME), a major cause of visual
impairment in diabetic patients, affects up to 21 million of the
93 million patients with diabetic retinopathy (DR) world-
wide.1 The retinal swelling in DME is caused by breakdown
of the blooderetinal barrier and leaking microaneurysms.
Because vascular endothelial growth factor (VEGF) is the
primary factor for retinal vascular hyperpermeability, anti-
VEGF agents are used as the primary therapy for DME,
effectively improving macular edema and vision in most pa-
tients.2 In contrast, in the case of anti-VEGFeresistant DME,
which suggests chronic inﬂammation, corticosteroids are an
alternative treatment option.3 Because the cost of anti-
VEGF agents is a major burden for patients with DME,4 it
is necessary to identify factors in baseline examinations that
can predict the treatment response to anti-VEGF agents.2368 ª 2016 by the American Academy of Ophthalmology
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). Published by ElseFluorescein angiography (FA) is an important diagnostic
tool for investigating leaking microaneurysms and pooling
patterns in DME. However, FA cannot visualize the precise
structure of deep retinal layers where most microaneurysms
and hyperpermeable retinal capillaries are located.5 Because
spectral-domain (SD) optical coherence tomography (OCT)
provides cross-sectional images of the deep retinal layer,
several studies have categorized different patterns of DME
according to the combination of FA and OCT ﬁndings.6e9
These studies have performed morphologic analyses and
speculated about the pathogenesis of DME, but none of
these earlier reports evaluated the association with the
treatment response.
Optical coherence tomography angiography (OCTA), a
recently developed procedure, enables closer observation ofvier Inc.
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Lee et al  OCT Angiography of DMEthe blood ﬂow of each retinal capillary layer.10 Abnormalities
in capillary ﬂow density and microaneurysms from the deep
capillary layer have been demonstrated in patients with DR,
aspects that could not be evaluated with FA and OCT.11e14
Because the diabetic vascular change occurs primarily in
the deep retinal layer, we hypothesized that the integrity of
the deep capillary plexus (DCP) might be associated with the
pathogenesis and treatment response of DME. We also
investigated baseline SD OCT ﬁndings associated with the
response of DME to anti-VEGF treatment.Methods
Patients
This retrospective case-control study included 55 patients with type
2 diabetes who were diagnosed with DR using FA and underwent
comprehensive ophthalmologic examinations, including SD OCT
and OCTA, in the Department of Ophthalmology at Asan Medical
Center, Seoul, Korea. The clinical severity of DR in each patient
was classiﬁed using the International Clinical Diabetic Retinopathy
and Diabetic Macular Edema Severity Scale.15 Eyes with any stage
of DR were included in this study. We included treatment-naïve
eyes and eyes that received previous anti-VEGF or panretinal
photocoagulation treatments more than 6 months before the base-
line. We deﬁned DME as a central retinal thickness greater than
300 mm. The cases were DME eyes that poorly responded to anti-
VEGF agents, and the controls were age-matched DME eyes with a
good response to anti-VEGF agents. A response to anti-VEGF
agents was deﬁned as a reduction of more than 50 mm in central
retinal thickness after 3 consecutive anti-VEGF injections. A poor
response to anti-VEGF agents was deﬁned as no reduction, a
reduction less than 50 mm, or an increase in central retinal thick-
ness after 3 consecutive monthly anti-VEGF injections compared
with the initial value observed 4 months previously.
We allowed a 1-week variation for everymonthly dosing interval.
Optical coherence tomography angiography was performed within 2
months of the last consecutive injection of anti-VEGF agent. We
selected 20 DR eyes with no history of DME from among the fellow
eyes of 55 case and control patients. These non-DME eyes were
deﬁned by any visible microaneurysm on FA but no evidence of
DMEon SDOCT. The anti-VEGF agents used in this study included
bevacizumab (76 eyes), ranibizumab (4 eyes), and aﬂibercept (3
eyes).We did not include any patients with a history of a vitrectomy,
other retinal vascular diseases, severe cataracts, or DME previously
treated with intravitreal or periocular corticosteroids. Eyes that could
not be scanned using SD OCT or with poor OCTA images with a
signal strength index<40 due tomedia opacity or signiﬁcant motion
artifact resulting from poor patient cooperation also were excluded
from the study.We evaluated the baseline systemic characteristics of
patients, including diabetic duration, presence of hypertension, and
glycosylated hemoglobin, within the preceding 3months. This study
was approved by the Institutional Review Board and Ethics Com-
mittee of Asan Medical Center.
Optical Coherence Tomography and Optical
Coherence Tomography Angiography
We performed SD OCT (Spectralis; Heidelberg Engineering,
Heidelberg, Germany) at every visit including the baseline exam-
ination. A custom 2020 volume acquisition protocol was used
to obtain a set of high-speed scans from each eye. With this pro-
tocol, 25 horizontal and central vertical cross-sectional B-scan
images were obtained, each composed of 512 A-scans. To improveimage quality, 25 to 30 frames were averaged for each B-scan. Of
the 25 B-scan images obtained, 1 image with the maximum height
of the largest intraretinal cyst was exported to analyze the optical
density ratio (ODR). We analyzed the central retinal thickness in
the standard 9-area Early Treatment of Diabetic Retinopathy Study
grid and total macular volume.
For the OCTA, AngioVue (Optovue Inc., Fremont, CA) was
used to obtain split-spectrum amplitude-decorrelation angiography
as previously described by Spaide et al.10 The scanning area was
captured in 33-mm sections and was centered on the fovea.
Optical coherence tomography angiography was performed after
the eyes were classiﬁed as anti-VEGF responders or poor re-
sponders to anti-VEGF treatment. Although there are multiple
retinal capillary planes that communicate through the vertical
branches in the retina, we simply measured the superﬁcial capillary
plexus (SCP) in the ganglion cell layer and the DCP beneath the
inner plexiform layer (IPL). We used auto-segmentation software
as follows: The en face image was segmented with an inner
boundary 15 mm beneath the IPL, and the outer boundary was set at
70 mm beneath the IPL to obtain images of the DCP. In the case of
incorrect segmentation, we manually adjusted the boundary be-
tween the SCP and the DCP. Multilayer-involving large intraretinal
cysts frequently caused errors in the accurate detection of IPL,
which is the reference layer for dividing the SCP and DCP. If the
border between the SCP and DCP was not located within the range
of the IPL, we deﬁned this as an inaccurate segmentation.
Although the auto-segmentation set the retinal thickness of the
DCP at 55 mm by default, we manually adjusted the offset values
of the inner and outer border of the DCP so that the segmentation
lines covered the full thickness of the inner nuclear layer and outer
plexiform layer (OPL). If the segmentation error with an irregularly
wavy border was not resolved by this manual extension of the DCP
range, we used the ﬂatten band tools and moved the outer border
into the outer nuclear layer to accurately measure the DCP. In
addition, we obtained images of the total capillary plexus (TCP) to
determine the entire retinal thickness via the ﬂattening and manual
extension of the SCP outer border.
Image Analysis and Statistical Analysis
To quantify the OCTA images, we measured the vascular ﬂow
density and foveal avascular zone (FAZ) area and counted the
number of microaneurysms in each layer (Fig S1, available at
www.aaojournal.org). Saccular capillary ends and fusiform
dilation 2-fold thicker than the capillary diameter were deﬁned as
microaneurysms in this study. The number of microaneurysms in a
33-mm area of each vascular layer was manually counted by 2
retinal specialists (J.L. and B.G.M.). The FAZ area was deﬁned as
an avascular central area, and the border of the FAZ was manually
drawn by 2 retinal specialists (J.L. and B.G.M.) who were blind to
all clinical information. These specialists started with the raw
images, did their own segmentation correction, and then analyzed
the images. The intraclass correlation coefﬁcient was used to
determine the interobserver agreement for the manually counted
number of microaneurysms and measured FAZ area. Interobserver
agreement, in terms of the manual measurements of micro-
aneurysms and FAZ area, was satisfactory (intraclass correlation
coefﬁcients of 0.913 and 0.934, respectively). The FAZ area and
vascular ﬂow density of images from a 33-mm area of each
vascular layer were calculated after conversion of the images to 8-
bit grayscale images using ImageJ software, as previously
described.16
In SD OCT images, we measured the ODR of the largest
intraretinal cyst to the vitreous humor using ImageJ 1.48 software
(National Institutes of Health, Bethesda, MD) as previously
described but with minor modiﬁcations.17 The entire intraretinal2369
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selected for the set measurement of the optical density. The
optical densities were extracted from the measured gray-level
intensity of the corresponding region on a scale of 0 (pure black)
to 255 (pure white). The selected areas were measured in pixels.
The ODR was calculated from the measured optical densities
(Fig S2, available at www.aaojournal.org). The integrity of the
OPL was evaluated in all horizontal and vertical B-scan images.
We deﬁned the OPL as being disrupted if the OPL was
discontinued at any image among 25 B-scans and cysts from
both nuclear layers communicated across the OPL disruption.
All statistical analyses were performed using the Statistical
Package for the Social Sciences (version 21.0; SPSS Inc., an IBM
Company, Chicago, IL). Continuous variables are presented as the
mean  standard deviation. Comparisons between groups were
evaluated using the Student t test, chi-square test, or Fisher exact
test, as appropriate. Analysis of variance with post hoc Tukey
honest signiﬁcant difference was used to compare the 3 groups. A
P value <0.05 was considered statistically signiﬁcant.
Results
Eye Characteristics
A total of 103 eyes from 55 patients (32 male and 23 female) with
DR at different clinical stages were included in this study. The
cases comprised 51 DME eyes with a poor response to anti-VEGF
agents, and the age-matched controls comprised 32 DME eyes with
a good response to anti-VEGF agents; the other 20 eyes were non-
DME fellow eyes of the cases and controls. Although the clinical
stage of DR was more severe and a trend toward a higher preva-
lence of hypertension in the DME groups was evident, no other
baseline demographics differed between the groups (Table 1).
Association of the Deep Capillary Plexus with
the Response to AntieVascular Endothelial
Growth Factor Treatment
We ﬁrst compared the OCTA ﬁndings between DME eyes that
responded to anti-VEGF agents and those that poorly responded to
anti-VEGF agents. In both groups, the mean number of micro-
aneurysms and mean area of the FAZ were higher in the DCP than
in the SCP, but the mean vascular ﬂow density was lower in the
DCP than in the SCP (Table 2, Figs 3 and 4). Compared with the
DME eyes considered to be anti-VEGF responders, poor responder
DME eyes exhibited more microaneurysms, lower vascular ﬂow
density, a larger FAZ area in the DCP, and a lower ﬂow density in
the TCP, whereas there were no signiﬁcant differences between the
2 groups in these parameters in the SCP (Table 2). The discrepancy
in the DCP parameters between the 2 groups suggests that the
integrity of the perifoveal DCP, but not that of the SCP, is
associated with the treatment response to anti-VEGF agents.
Association of the Deep Capillary Plexus with
the Occurrence of Diabetic Macular Edema
The aforementioned results encouraged us to compare the integrity
of the DCP between DME and non-DME eyes. We selected 20
fellow eyes without a history of DME from 55 patients. There were
signiﬁcant differences in the number of microaneurysms and the
vascular ﬂow density in the DCP and TCP between DME eyes and
non-DME eyes (Table 3). These differences were still signiﬁcant
even when the poor responder DME eyes were excluded to
avoid the possibility that the DME group might be biased toward
severe DME (Table S4, available at www.aaojournal.org).2370However, the difference of the vascular density in the SCP
between the DME and non-DME eyes did not quite reach
the level of signiﬁcance. Next, we investigated whether the clinical
stage of DR was associated with the ﬂow density of the
DCP in DME. Compared with DME eyes with nonproliferative DR
(n¼ 41), DME eyes with proliferative DR (n¼ 42) had a larger mean
FAZ area in the DCP (Table S5, available at www.aaojournal.org).
However, no other OCTA ﬁndings in the DCP and SCP were
signiﬁcantly different between the nonproliferative DR and
proliferative DR groups. Therefore, this discrepancy in the
parameters of the DCP between the groups suggests that integrity of
the perifoveal DCP is involved in the pathogenesis of DME but is
not associated with the clinical stage of DR.
Baseline Spectral-Domain Optical Coherence
Tomography Findings Associated with the
Response to AntieVascular Endothelial Growth
Factor Treatment
We investigated whether the baseline SD OCT ﬁndings were
associated with the response to anti-VEGF treatment in DME eyes.
First, we measured the ODR of the largest intraretinal cyst to the
vitreous. Compared with the good responder DME eyes, poor
responder DME eyes exhibited a higher ODR at both baseline and
after treatment (Table 6). Notably, in the poor responder DME
eyes, the ODR signiﬁcantly increased after treatment with anti-
VEGF drugs (Table 6).
Next, we closely observed the integrity of the OPL where the
DCP is located. In total, 47 eyes of the 51 poor responder DME
eyes presented multiple instances of disruption of the synaptic OPL
and thus intraretinal cyst communication between the inner and
outer nuclear layers (Table 6, Fig 5). In contrast, only 1 eye of the
32 anti-VEGF good responder DME eyes displayed these ﬁndings.
The topographic location of the disrupted OPL in SD OCT exactly
corresponded to the nonﬂow area of the DCP in OCTA (Fig 5F and
G). Notably, the disruption in the OPL was not recovered even
after the edema improved, which suggests that there might be
permanent damage (Fig 5H). In patients with a relatively intact
DCP, the integrity of the OPL was preserved even in the
numerous retinal cysts in both the inner and outer nuclear layers
(Fig 5AeD).
Discussion
Our current results suggest that microvascular damage in the
DCP is strongly associated with the treatment response to
anti-VEGF agents in patients with DME. In contrast to
DME eyes responding well to anti-VEGF drugs, poor
responder DME eyes showed a signiﬁcantly lower ﬂow
density, larger number of microaneurysms, and larger area
of the FAZ in the DCP. Although some previous OCTA
studies have reported more severe microvascular abnor-
malities in the DCP than in the SCP among eyes with DR or
DME,11,12 no study has previously compared the degree of
microvascular damage in relation to the treatment response
to anti-VEGF agents.
Although the exact pathogenesis of DME has not been
fully elucidated, the VEGF-mediated breakdown of the
blooderetinal barrier seems to be the primary pathologic
process that triggers the subsequent inﬂammatory re-
actions.18 Therefore, anti-VEGF therapy has been approved
as a primary modality in the treatment of DME via several
clinical trials.2,18 Nevertheless, there are still concerns about
Table 1. Demographic Information on the Diabetic Macular
Edema and Nondiabetic Macular Edema Eyes
Poor
Responder
DME
(n [ 51)
Good
Responder
DME
(n [ 32)
No DME
(n [ 20)
P
Value
Mean age (SD), yrs 59.3 (8.8) 57.5 (10.3) 60.5 (8.6) 0.483
Range, yrs 39e79 39e79 44e74
Male, n (%) 31 (60.8) 17 (53.1) 13 (65.0) 0.663
Duration of
diabetes, yrs
12.6 (7.0) 11.7 (8.0) 10.4 (7.5) 0.522
Duration of DR, mos 20.4 (19.2) 14.2 (17.4) 13.7 (17.8) 0.217
Positive history of
hypertension,
n (%)
22 (43.1) 13 (40.6) 3 (15.0) 0.076
HbA1c, % 7.9 (1.7) 7.6 (1.7) 8.5 (1.9) 0.171
Clinical severity of
DR, n (moderate
NPDR/severe
NPDR/PDR)
0/26/25 0/15/17 4/12/4 <0.001
DME ¼ diabetic macular edema; DR ¼ diabetic retinopathy; HbA1c ¼
glycosylated hemoglobin; NPDR ¼ nonproliferative diabetic retinopathy;
PDR ¼ proliferative diabetic retinopathy; SD ¼ standard deviation.
Table 2. Comparisons of Optical Coherence Tomography
Angiography Parameters in Diabetic Macular Edema According to
the Response to AntieVascular Endothelial Growth Factor
Treatment
Poor
Responder
DME (n [ 51)
Good
Responder
DME (n [ 32)
P
Value
SCP
Microaneurysms, n 0.7 (0.9) 0.3 (0.7) 0.070
Vascular ﬂow
density, %
21.81 (3.71) 21.94 (3.34) 0.884
Foveal
avascular area, mm2
0.33 (0.16) 0.34 (0.18) 0.954
DCP
Microaneurysms, n 8.9 (4.1) 3.9 (1.2) <0.001
Vascular ﬂow
density, %
10.62 (4.66) 17.39 (3.98) <0.001
Foveal avascular area, mm2 0.87 (0.41) 0.57 (0.22) <0.001
TCP
Vascular ﬂow
density (SD), %
24.69 (4.39) 26.63 (4.05) 0.043
DCP ¼ deep capillary plexus; DME ¼ diabetic macular edema; SCP ¼
superﬁcial capillary plexus; TCP ¼ total capillary plexus.
Data are mean (standard deviation) unless otherwise indicated.
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VEGF-resistant cases because multiple injections might
place a considerable burden on diabetic patients and the
social economy.4 To avoid ineffective repeated injections, it
is important to screen for anti-VEGF-resistant DME in
baseline examinations. Although several studies have
evaluated the hard exudate or inﬂammatory status to
identify variables predicting the treatment response,3,19 we
focused on the structure of the retinal blood vessel itself
because VEGF targets the endothelial cells of blood vessels.
The underlying mechanism of the association between
the low-ﬂow density in the DCP and treatment resistance to
anti-VEGF agents remains to be clearly deﬁned. There are
several possible explanations for this association. One pos-
sibility is that protein-rich intraretinal cysts alter the ability
of anti-VEGF agents to diffuse from the vitreous to the
DCP, where the hyperpermeable retinal capillaries are
located. The second possible explanation is that abundant
expression of VEGF in the ischemic deep retina in the
absence of the DCP restricts the efﬁcacy of anti-VEGF
agents. A third possibility is that inhibition of VEGF
might not be able to restore absent or broken vessels
because it produces a selective tightening effect on endo-
thelial junctions. Finally, the DCP might participate in the
removal of excess ﬂuid from the retina20; its absence could
predispose the retina to the localized accumulation of ﬂuid.
Thus, a smaller DCP would reduce ﬂuid absorption, even
though capillary permeability is inhibited by anti-VEGF
agents.
Fluorescein angiography is considered the gold standard
for evaluating microvascular structure and its functional role
in retinal blood vessels. However, the ability of FA to
visualize the DCP is limited by the superposition of the SCP
and overlying leakage.21 Signals from excited sodium
ﬂuorescein in the DCP cannot penetrate retinal layers butare absorbed by the inner retinal tissue.21 Thus, previous
studies that used FA to investigate the microvascular
structure in DR have limitations in that they did not
precisely observe the DCP, which is where the diabetic
vascular change primarily occurs.
Since OCTA has recently become available, the impor-
tance of the DCP in several retinal diseases has been
emphasized. Nevertheless, the functional roles of the DCP
in terms of oxygen supply to the outer retina are still
obscure. Although the outer one third of the retina is mainly
supplied by the choriocapillaris, the DCP provides approx-
imately 15% of the oxygen supply of the photoreceptors.22
A steady decrease in the gradient of oxygen from the
choriocapillaris to the photoreceptors has been
experimentally proven.23 In the absence of the DCP,
bipolar cells in the inner nuclear layer are vulnerable to
hypoxic cell death, and electroretinography has revealed
decreased post-photoreceptor responses.24 On the basis of
these previous observations, we can assume that the DCP
provides oxygen to the inner and outer nuclear layers.
Therefore, the OPL and the region just below it may act
as a watershed zone and could be especially vulnerable to
ischemic damage from the DCP.25 In this context, the
OPL at the region where the ﬂow of DCP is absent could
be disrupted.
There are concerns about the low reliability of OCTA
and its poor visualization of the DCP in patients with
macular edema. Indeed, a lack of visualization of ﬂow in
OCTA does not necessarily mean that ﬂow is completely
absent. Spaide20 recently reported that the extent of ﬂow
void is not exactly matched with the cystoid space. The
cystoid space may compress the vessels or, conversely,
ﬂuid may preferentially accumulate in the region of low
ﬂow in the DCP. These mutual effects suggest that the2371
Figure 3. A diabetic macular edema (DME) eye showing a good response to antievascular endothelial growth factor treatment. Baseline fundus
photography (A) and ﬂuorescein angiography (FA) (B) of the eye. Optical coherence tomography angiography showing multiple microaneurysms in the
deep capillary plexus (D), but none in the superﬁcial capillary plexus (C). Yellow circles indicate microaneurysms that were not depicted on FA. Red circles
indicate a microaneurysm that is also seen on the FA images. Compared with the baseline spectral-domain optical coherence tomography (SD OCT)
(E), the follow-up SD OCT (F) showed improved macular edema after 3 bevacizumab injections.
Ophthalmology Volume 123, Number 11, November 2016OCTA information is not valueless but can be useful to
investigate the pathogenesis of DME if carefully
interpreted. In this study, we carefully adjusted the
boundary between the SCP and DCP in the eyes with
severe DME and conﬁrmed the difference in the DCP byFigure 4. A diabetic macular edema (DME) eye showing a poor response
photography (A) and ﬂuorescein angiography (FA) (B) of the eye. The optica
superﬁcial capillary plexus (SCP) (C) and the deep capillary plexus (DCP) (D).
the DCP compared with the relatively preserved vascular ﬂow density in the S
indicate microaneurysms that were also seen on the FA images. In the follow-u
was not signiﬁcantly improved after 3 bevacizumab injections (F) compared wi
2372calculating the TCP for the entire retinal thickness to
overcome segmentation issues. In addition, OCTA was
performed after treatments when the macular edema
improved in most of the eyes. Therefore, the bias from the
cystoid space was minimized in this analysis. Our resultsto antievascular endothelial growth factor treatment. Baseline fundus
l coherence tomography angiography showed microaneurysms in both the
A lower vascular ﬂow density was seen in the large foveal avascular area in
CP. Yellow circles indicate microaneurysms not depicted by FA. Red circles
p spectral-domain optical coherence tomography SD OCT, macular edema
th the baseline SD OCT (E).
Table 3. Comparisons of Optical Coherence Tomography
Angiography Parameters in Diabetic Retinopathy with or without
Diabetic Macular Edema
DME
(n [ 83)
No DME
(n [ 20)
P
Value
SCP
Microaneurysms, n 0.5 (0.9) 0 (0) <0.001
Vascular ﬂow
density, %
21.87 (3.55) 23.43 (3.43) 0.078
Foveal avascular
area, mm2
0.34 (0.17) 0.31 (0.13) 0.551
DCP
Microaneurysms, n 6.2 (4.7) 0 (0) <0.001
Vascular ﬂow
density, %
13.23 (5.49) 20.75 (3.48) <0.001
Foveal avascular
area, mm2
0.76 (0.38) 0.49 (0.14) <0.001
TCP
Vascular ﬂow
density (SD), %
25.44 (4.34) 29.04 (4.13) 0.002
DCP ¼ deep capillary plexus; DME ¼ diabetic macular edema; SCP ¼
superﬁcial capillary plexus; TCP ¼ total capillary plexus.
Data are mean (standard deviation) unless otherwise indicated.
Table 6. Comparisons of Spectral-Domain Optical Coherence
Tomography Angiography Parameters in Diabetic Macular Edema
According to the Response to Anti-Vascular Endothelial Growth
Factor Treatment
Poor
Responder
DME (n [ 51)
Good
Responder
DME (n [ 32)
P
Value
Baseline SD OCT ﬁndings
Central retinal
thickness, mm
482.7 (149.3) 442.3 (164.6) 0.251
Total macular
volume, mm3
11.8 (2.0) 11.0 (1.7) 0.066
ODR of intraretinal
cyst to vitreous
3.6 (2.6)* 2.1 (1.3)y <0.001
Positive in OPL
disruption, n (%)
47 (90.4) 1 (3.1) <0.001
Follow-up SD OCT ﬁndings
after anti-VEGF treatments
Central retinal
thickness, mm
493.7 (128.5) 328.9 (77.7) <0.001
Total macular
volume, mm3
11.5 (1.9) 9.9 (0.9) <0.001
ODR of intraretinal
cyst to vitreous
4.7 (3.4)* 2.2 (1.4)y <0.001
Positive in OPL
disruption, n (%)
49 (96.1) 2 (6.3) <0.001
DME ¼ diabetic macular edema; ODR ¼ optical density ratio; OPL ¼
outer plexiform layer; SD OCT ¼ spectral-domain optical coherence
tomography.
Data are mean (standard deviation) unless otherwise indicated.
*Poor responder ODR paired t test. P ¼ 0.046.
yGood responder ODR paired t test. P ¼ 0.417.
Lee et al  OCT Angiography of DMEare further supported by Pearson correlation analysis
demonstrating that the density of the DCP was not
signiﬁcantly associated with retinal thickness or volume at
baseline and after treatment (Table S7, available at
www.aaojournal.org).
For the improvement of OCTA reliability, motion artifact
and reproducibility have been critical issues. In this study,
we overcame any limitations that may have derived from
motion artifacts by excluding poor-quality images with a
low signal strength index. Stable ﬁxation of patients and a
precise centration technique at the follow-up examination
are necessary for OCTA reproducibility. Although the
excellent reproducibility of FAZ in healthy subjects has
been reported,26 intraobserver and interobserver variability
in diseased eyes need to be assessed in future studies.
In this study, as a predictor of the treatment responsive-
ness to anti-VEGF agents, we also showed OPL line
disruption on SD OCT. Because OCTA is not yet widely
available, we concentrated on detecting the corresponding
feature of the DCP loss in SD OCT images in DME eyes.
Given that the DCP is located at the junction between the
inner nuclear layer and OPL, we hypothesized that blood
ﬂow in the DCP might be primarily responsible for the
integrity of the synaptic portion of the OPL where the syn-
apse between bipolar cells and photoreceptor cells occurs.
The disruption of the OPL in SD OCT topographically cor-
responded to the nonﬂow area in the DCP. Because the OPL
acts as a ﬂuid barrier,27 intraretinal cysts between the inner
and outer nuclear layers communicated through the
disrupted OPL. In addition, disruption of the layered retinal
structure can predict visual acuity in eyes with DME.28
Thus, the association between DCP integrity and visual
prognosis will be evaluated in a future study. The other SD
OCT ﬁnding associated with the response to anti-VEGF
treatment was the optical density of the intraretinal cysts.Chronic inﬂammation with highly exudative DME might
cause protein-rich intraretinal cysts that appear as hyper-
reﬂective signals on SD OCT, as in other retinal diseases.17,29
Study Limitations
There are some noteworthy limitations of this retrospective
study. Our study series comprised patients with differing
previous treatments and DME durations. Other confounding
factors including extrafoveal leaking microaneurysms or hard
exudates may have inﬂuenced the responsiveness to
anti-VEGF agents. In addition, our quantiﬁcation of the
microaneurysm number and FAZ area included a subjective
process because no reliable software for this analysis is
currently available. However, it must be noted that our
quantiﬁcation methods demonstrated an excellent level of
interobserver agreement. To obtain accurate ﬂow maps in
OCTA, patients must have good ﬁxation to prevent signiﬁ-
cant motion artifacts. Many patients with severe DME have
poor vision, restricting the usefulness of OCTA, and were
thus excluded from our analysis.
In conclusion, we reveal that the integrity of the DCP is
important not only for the occurrence of DME but also for
the treatment response to anti-VEGF agents. Therefore, the
extent of DCP loss assessed by OCTA could be a useful
diagnostic tool for predicting the treatment response to anti-
VEGF agents. In addition, the disruption of the OPL in SD
OCT corresponds well with the extent of DCP loss and
thus could be an alternative predictor of anti-VEGF2373
Figure 5. Comparison of the integrity of the outer plexiform layer (OPL) according to the response to antievascular endothelial growth factor treatment.
AeD, A good responder diabetic macular edema (DME) eye. EeH, A poor responder DME eye. The disrupted OPL in spectral-domain optical coherence
tomography (G and H, yellow dotted lines, arrows) exactly corresponded to the nonﬂow area (F, red dotted lines) of the deep capillary plexus in optical
coherence tomography angiography. H, Disruption of the OPL was not repaired, even after the edema improved with treatment. C and D, The integrity of
the OPL was preserved (yellow dotted lines), even in the numerous retinal cysts in the eye of a patient with good responder DME.
Ophthalmology Volume 123, Number 11, November 2016responsiveness in DME eyes. Our present ﬁndings could be
useful for further studies evaluating the longitudinal changes
in the DCP after anti-VEGF treatment.References
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